Showing 5321-5330 of 6808 results for "".
- ASLMS: CellFX from Pulse Offers Durable Clearance of SH Lesionshttps://practicaldermatology.com/news/aslms-cellfx-from-pulse-offers-durable-clearance-of-sh-lesions/2461183/The CellFX® system from Pulse Biosciences, Inc. demonstrates durable efficacy for the clearance of Sebaceous Hyperplasia lesions, according to data presented at the 2022
- Pathologist Survey: Melanoma Is Overdiagnosedhttps://practicaldermatology.com/news/pathologist-survey-melanoma-is-overdiagnosed/2461180/Many pathologists agree that overdiagnosis of skin cancer happens, but don’t change diagnosis behavior, according to a new study. “Overdiagnosis is the diagnosis of disease that will not harm a person in their lifetime. If melanoma is being overdiagnosed, it means that too m
- Cutera Hosts AviClear Webinar This Weekhttps://practicaldermatology.com/news/cutera-hosts-aviclear-webinar-this-week/2461178/Cutera hosts the first webinar for AviClear, the first and only FDA cleared energy-based device for the treatment of mild, moderate, and severe acne, this week. Dermatologists Jeffrey S. Dover, MD, FRCPC and Julie C. Harper, MD will discuss the latest advancement in the treatment of acn
- Chicago Dermatological Society to Host Art of Skin Gala to Advance Diversity, Equity, and Inclusionhttps://practicaldermatology.com/news/chicago-dermatological-society-to-host-art-of-skin-gala-to-advance-diversity-equity-and-inclusion/2461176/The Chicago Dermatological Society (CDS) is launching the Art of Skin Gala, sponsored by Janssen Biotech, Inc. The event, to be held June 10, is described as a live, in color celebration of diversity, equity, and inclusion brought to life through the beauty of skin. The
- ePatch Using Electrical Field Stimulation Shows Promise for Wound Healinghttps://practicaldermatology.com/news/epatch-using-electrical-field-stimulation-shows-promise-for-wound-healing/2461175/A “smart” flexible electric patch (ePatch) developed by a collaborative team from the Terasaki Institute for Biomedical Innovation promises to address the challenges posed by existing electrical field (EF) stimulation devices for wound healing and offers many uniquely advantageous fea
- Actress Lily Collins is New Living Proof Ambassadorhttps://practicaldermatology.com/news/actress-lily-collins-is-new-living-proof-ambassador/2461174/Actress Lily Collins is the new ambassador for Living Proof. The partnership kicked off with a new brand campaign celebrating its mission of sci
- FDA Approves Sol-Gel Technologies' and Galderma's Epsolay for Rosaceahttps://practicaldermatology.com/news/fda-approves-sol-gel-technologies-and-galdermas-epsolay-for-rosacea/2461170/The FDA has approved Sol-Gel Technologies' Epsolay, a proprietary cream formulation of benzoyl peroxide, 5%, for the treatment of inflammatory lesions of rosacea in adults. The benzoyl peroxide in Epsolay is encapsulated within silica-based patented microcapsules. The silica-based s
- Virtual Skin Cancer Symposium® + Symposium for Inflammatory Skin Disease® Coming Soonhttps://practicaldermatology.com/news/virtual-skin-cancer-symposium-symposium-for-inflammatory-skin-disease-coming-soon/2461166/The 2nd Annual Skin Cancer Symposium® + Symposium for Inflammatory Skin Disease® (SCS + SISD) will be held virtually June 10-12, 2022. Fifteen well-known speakers will deliver 15 hours of CME credit on topics such as BCC, SCC, melanoma, actinic keratosis, dermosc
- Cutera to Celebrate AviClear Launch at ASLMShttps://practicaldermatology.com/news/cutera-to-celebrate-aviclear-launch-at-aslms/2461165/Cutera is celebrating the launch of AviClear, the first and only FDA cleared energy-based device for the treatment of mild, moderate, and severe acne, during the ASLMS meeting in San Diego. ASLMS attendees are invited to the celebration for the launch of AviClear on Thursday, April 28,
- Castle's Non-Invasive Gene Expression Profile Test Can Predict Response to Systemic Therapy in Patients with Inflammatory Skin Diseaseshttps://practicaldermatology.com/news/castles-gene-expression-profile-test-can-predict-response-to-systemic-therapy-in-patients-with-inflammatory-skin-diseases/2461163/Castle Biosciences, Inc.’s non-invasive skin scraping technique produces sufficient ribonucleic acid (RNA) to assess reproducible gene expression for its inflammatory skin disease pipeline test, according to a poster was presented at the 4th Annual Revolutionizing Atopic Der